Over 50 non-Covid studies to restart

Over 50 research studies in diseases other than Covid-19 have been the green light to restart at UCLH.

The studies – including obstetrics and cancer trials – will now be able to resume work having been paused due to the Covid-19 pandemic.

Decisions on restarting trials are based on ensuring the safety of patients and staff and minimal disruption to clinical services, with a particular focus on reducing the number of hospital visits required and the burden on PPE equipment. The capacity and of the Trust’s pharmacy and pathology services are also major considerations.